blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2010148

EP2010148 - COMPOSITION INCLUDING AT LEAST ONE AQUEOUS PHASE AND AT LEAST ONE FATTY PHASE INCLUDING IVERMECTIN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.05.2017
Database last updated on 19.10.2024
Most recent event   Tooltip06.03.2020Lapse of the patent in a contracting state
New state(s): TR		published on 08.04.2020  [2020/15]
Applicant(s)For all designated states
Galderma S.A.
Zugerstrasse 8
6330 Cham / CH
[2016/26]
Former [2009/02]For all designated states
Galderma S.A.
Zugerstrasse 8
6330 Cham / CH
Inventor(s)01 / DIAZ-ASTRUC, Fanny
12134 Meadow lake Drive
Houston, TX 77077 / US
02 / BARTHEZ, Nathalie
La Valériane
91, avenue des Oliviers
F-06700 Saint Laurent du Var / FR
03 / SEGURA-ORSONI, Sandrine
Les Jardins de Mandelieu
522, rue de Boeri
F-06210 Mandelieu / FR
 [2016/26]
Former [2009/10]01 / DIAZ-ASTRUC, Fanny
12134 Meadow lake Drive
Houston, TX 77077 / US
02 / BARTHEZ, Nathalie
La Valériane 91, avenue des Oliviers
F-06700 Saint Laurent du Var / FR
03 / SEGURA-ORSONI, Sandrine
Les Jardins de Mandelieu 522, rue de Boeri
F-06210 Mandelieu / FR
Former [2009/02]01 / DIAZ-ASTRUC, Fanny
12134 Meadow lake Drive
Houston, TX 77077 / US
02 / BARTHEZ, Nathalie
Le Nicea Bat C 31, rue de Roquebillière
F-06300 Nice / FR
03 / SEGURA-ORSONI, Sandrine
Les Jardins de Mandelieu 522, rue de Boeri
F-06210 Mandelieu / FR
Representative(s)Casalonga
Casalonga & Partners
Bayerstraße 71/73
80335 München / DE
[2013/06]
Former [2012/32]Andral, Christophe André Louis, et al
L'OREAL
D.I.P.I.
25/29 Quai Aulagnier
92665 Asnières-Sur-Seine Cedex / FR
Former [2009/50]Allab, Myriam, et al
L'Oréal D.I.P.I. 25-29 Quai Aulagnier
92600 Asnières / FR
Former [2009/02]Allab, Myriam, et al
L'Oreal - D.I.P.I. River Plaza 25-29 Quai Aulagnier
92665 Asnières-sur-Seine / FR
Application number, filing date07731904.418.04.2007
[2009/02]
WO2007FR51128
Priority number, dateFR2006000345219.04.2006         Original published format: FR 0603452
[2009/02]
Filing languageFR
Procedural languageFR
PublicationType: A2 Application without search report
No.:WO2007119028
Date:25.10.2007
Language:FR
[2007/43]
Type: A2 Application without search report 
No.:EP2010148
Date:07.01.2009
Language:FR
The application published by WIPO in one of the EPO official languages on 25.10.2007 takes the place of the publication of the European patent application.
[2009/02]
Type: B1 Patent specification 
No.:EP2010148
Date:29.06.2016
Language:FR
[2016/26]
Search report(s)International search report - published on:EP03.04.2008
ClassificationIPC:A61K9/107, A61K31/7048, A61P17/00, A61P17/08, A61P17/10, A61K47/14, A61K47/44, A61K47/10
[2009/02]
CPC:
A61K31/7048 (EP,US); A61K45/06 (US); A61K9/0014 (EP,US);
A61K9/107 (EP,US); A61P17/00 (EP); A61P17/08 (EP);
A61P17/10 (EP); A61K47/10 (EP,US); A61K47/14 (EP,US);
A61K47/32 (EP,US); A61K47/34 (EP,US); A61K47/44 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/26]
Former [2009/02]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:ZUSAMMENSETZUNG MIT MINDESTENS EINER WÄSSRIGEN PHASE UND MINDESTENS EINER FETTPHASE MIT IVERMECTIN[2009/02]
English:COMPOSITION INCLUDING AT LEAST ONE AQUEOUS PHASE AND AT LEAST ONE FATTY PHASE INCLUDING IVERMECTIN[2009/02]
French:COMPOSITION COMPRENANT AU MOINS UNE PHASE AQUEUSE ET AU MOINS UNE PHASE GRASSE COMPRENANT DE L'IVERMECTINE[2009/02]
Entry into regional phase19.11.2008National basic fee paid 
19.11.2008Designation fee(s) paid 
19.11.2008Examination fee paid 
Examination procedure19.11.2008Examination requested  [2009/02]
06.07.2009Despatch of a communication from the examining division (Time limit: M06)
15.01.2010Reply to a communication from the examining division
31.01.2012Despatch of a communication from the examining division (Time limit: M06)
27.07.2012Reply to a communication from the examining division
09.07.2015Despatch of a communication from the examining division (Time limit: M04)
23.09.2015Reply to a communication from the examining division
08.12.2015Despatch of a communication from the examining division (Time limit: M02)
06.01.2016Reply to a communication from the examining division
29.01.2016Communication of intention to grant the patent
04.05.2016Fee for grant paid
04.05.2016Fee for publishing/printing paid
04.05.2016Receipt of the translation of the claim(s)
Divisional application(s)EP11173086.7  / EP2374449
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  06.07.2009
Opposition(s)30.03.2017No opposition filed within time limit [2017/23]
Fees paidRenewal fee
16.04.2009Renewal fee patent year 03
25.03.2010Renewal fee patent year 04
12.04.2011Renewal fee patent year 05
28.03.2012Renewal fee patent year 06
12.04.2013Renewal fee patent year 07
25.03.2014Renewal fee patent year 08
10.04.2015Renewal fee patent year 09
11.04.2016Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU18.04.2007
AT29.06.2016
CY29.06.2016
CZ29.06.2016
DK29.06.2016
EE29.06.2016
ES29.06.2016
FI29.06.2016
IT29.06.2016
LT29.06.2016
LV29.06.2016
MC29.06.2016
MT29.06.2016
NL29.06.2016
PL29.06.2016
RO29.06.2016
SE29.06.2016
SI29.06.2016
SK29.06.2016
TR29.06.2016
BG29.09.2016
GR30.09.2016
IS29.10.2016
PT31.10.2016
[2020/15]
Former [2019/46]HU18.04.2007
AT29.06.2016
CY29.06.2016
CZ29.06.2016
DK29.06.2016
EE29.06.2016
ES29.06.2016
FI29.06.2016
IT29.06.2016
LT29.06.2016
LV29.06.2016
MC29.06.2016
MT29.06.2016
NL29.06.2016
PL29.06.2016
RO29.06.2016
SE29.06.2016
SI29.06.2016
SK29.06.2016
BG29.09.2016
GR30.09.2016
IS29.10.2016
PT31.10.2016
Former [2019/31]HU18.04.2007
AT29.06.2016
CZ29.06.2016
DK29.06.2016
EE29.06.2016
ES29.06.2016
FI29.06.2016
IT29.06.2016
LT29.06.2016
LV29.06.2016
MC29.06.2016
MT29.06.2016
NL29.06.2016
PL29.06.2016
RO29.06.2016
SE29.06.2016
SI29.06.2016
SK29.06.2016
BG29.09.2016
GR30.09.2016
IS29.10.2016
PT31.10.2016
Former [2018/43]AT29.06.2016
CZ29.06.2016
DK29.06.2016
EE29.06.2016
ES29.06.2016
FI29.06.2016
IT29.06.2016
LT29.06.2016
LV29.06.2016
MC29.06.2016
MT29.06.2016
NL29.06.2016
PL29.06.2016
RO29.06.2016
SE29.06.2016
SI29.06.2016
SK29.06.2016
BG29.09.2016
GR30.09.2016
IS29.10.2016
PT31.10.2016
Former [2018/06]AT29.06.2016
CZ29.06.2016
DK29.06.2016
EE29.06.2016
ES29.06.2016
FI29.06.2016
IT29.06.2016
LT29.06.2016
LV29.06.2016
MC29.06.2016
NL29.06.2016
PL29.06.2016
RO29.06.2016
SE29.06.2016
SI29.06.2016
SK29.06.2016
BG29.09.2016
GR30.09.2016
IS29.10.2016
PT31.10.2016
Former [2017/38]AT29.06.2016
CZ29.06.2016
DK29.06.2016
EE29.06.2016
ES29.06.2016
FI29.06.2016
IT29.06.2016
LT29.06.2016
LV29.06.2016
NL29.06.2016
PL29.06.2016
RO29.06.2016
SE29.06.2016
SI29.06.2016
SK29.06.2016
BG29.09.2016
GR30.09.2016
IS29.10.2016
PT31.10.2016
Former [2017/11]AT29.06.2016
CZ29.06.2016
EE29.06.2016
ES29.06.2016
FI29.06.2016
IT29.06.2016
LT29.06.2016
LV29.06.2016
NL29.06.2016
PL29.06.2016
RO29.06.2016
SE29.06.2016
SK29.06.2016
GR30.09.2016
IS29.10.2016
PT31.10.2016
Former [2017/10]CZ29.06.2016
EE29.06.2016
FI29.06.2016
IT29.06.2016
LT29.06.2016
LV29.06.2016
NL29.06.2016
PL29.06.2016
RO29.06.2016
SE29.06.2016
SK29.06.2016
GR30.09.2016
IS29.10.2016
Former [2017/09]CZ29.06.2016
EE29.06.2016
FI29.06.2016
IT29.06.2016
LT29.06.2016
LV29.06.2016
NL29.06.2016
RO29.06.2016
SE29.06.2016
GR30.09.2016
Former [2016/52]FI29.06.2016
LT29.06.2016
LV29.06.2016
NL29.06.2016
SE29.06.2016
GR30.09.2016
Former [2016/51]FI29.06.2016
LT29.06.2016
LV29.06.2016
GR30.09.2016
Former [2016/49]FI29.06.2016
LT29.06.2016
Former [2016/46]LT29.06.2016
Cited inInternational search[DX]WO2004093886  (GALDERMA RES & DEV [FR], et al) [DX] 1-15 * page 1, line 3 - line 7 * * page 3, line 12 - line 23 * * page 4, line 20 - line 25 * * page 5, line 26 - page 12, line 3 * * page 12, line 24 - page 15, line 4 * * examples 1-7,9,10 * * claims 1-8,10-22 *;
 [DX]WO2005089806  (GALDERMA SA [CH], et al) [DX] 1-15 * page 1, line 1 - line 14 * * page 3, line 16 - line 23 * * page 8, line 9 - line 23 * * page 9, line 7 - page 10, line 10 * * page 11, line 10 - line 16 * * page 12, line 6 - page 14, line 10 * * page 15, line 19 - page 16, line 18 * * examples 1-9,11 * * claims 1-5,8-20 *;
 [X]WO0074489  (NUFARM LTD [NZ], et al) [X] 1-15 * page 1, line 1 - line 15 * * page 4, line 5 - page 5, line 12 * * page 14, line 17 - page 15, line 5 * * table 1 * * examples 7,12-16 * * tables 3-14 * * claims 1,2,9,10,14,16 *;
 [X]WO0042990  (OPTIME THERAPEUTICS INC [US], et al) [X] 1-13 * page 1, line 4 - line 6 * * page 2, line 22 - page 3, line 3 * * page 6, line 5 - line 9 * * page 8, line 4 - line 5 * * page 9, line 16 * * tables 1-3,6,8,9 * * page 13, line 7 - page 14, line 8 * * examples 1-4 * * claims 1-3,9-11,13-16,21,22,24-43,46,49,50,68-71,75-80 *;
 [X]GB2310801  (MERCK & CO INC [US]) [X] 1-9,12,13 * page 1, line 6 - line 7 * * page 2, line 32 - page 3, line 2 * * page 3, line 21 - line 28 * * claims 1,2,4,5 *;
 [X]WO0209764  (BYRON BASSETT LTD [NZ], et al) [X] 1-8,12,13 * page 1, line 4 - line 5 * * page 2, line 29 - page 3, line 7 * * page 3, line 21 - line 32 * * page 4, line 5 - line 16 * * examples 1-5 * * page 10, line 18 - line 22 * * claims 1-4,6,7,9-13 *;
 [PX]WO2006069580  (CHEMINOVA AS [DK], et al) [PX] 1-5,7-10,12,13 * page 1, line 1 - line 4 * * page 1, line 30 - page 2, line 2 * * page 3, line 17 - page 4, line 20 * * page 9, line 15 - line 22 * * examples 1-6,9-16 * * tables 1,9-13,15 * * claims 1,2,12,13 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.